Business Description
Molecular Partners AG
ISIN : CH0256379097
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 52.19 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.56 | |||||
Beneish M-Score | -1.29 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.9 | |||||
3-Year EBITDA Growth Rate | 8.7 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -14.1 | |||||
3-Year Book Growth Rate | 13.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | -4.75 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 54.12 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.43 | |||||
9-Day RSI | 95.77 | |||||
14-Day RSI | 87.85 | |||||
6-1 Month Momentum % | 17.55 | |||||
12-1 Month Momentum % | 23.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.58 | |||||
Quick Ratio | 14.58 | |||||
Cash Ratio | 14.01 | |||||
Days Sales Outstanding | 94.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | 0.65 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -788.24 | |||||
Net Margin % | -732.97 | |||||
FCF Margin % | -798.08 | |||||
ROE % | -31.92 | |||||
ROA % | -28.72 | |||||
ROIC % | -595.02 | |||||
3-Year ROIIC % | 6.58 | |||||
ROC (Joel Greenblatt) % | -1024.78 | |||||
ROCE % | -30.8 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 23.19 | |||||
PB Ratio | 1.18 | |||||
Price-to-Tangible-Book | 1.61 | |||||
EV-to-EBIT | -0.6 | |||||
EV-to-EBITDA | -0.62 | |||||
EV-to-Revenue | 4.38 | |||||
EV-to-FCF | -0.43 | |||||
Price-to-Projected-FCF | 12.06 | |||||
Price-to-Net-Current-Asset-Value | 1.66 | |||||
Price-to-Net-Cash | 1.74 | |||||
Earnings Yield (Greenblatt) % | -167.67 | |||||
FCF Yield % | -32.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Molecular Partners AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 7.862 | ||
EPS (TTM) (CHF) | -1.75 | ||
Beta | 0.47 | ||
Volatility % | 106.21 | ||
14-Day RSI | 87.85 | ||
14-Day ATR (CHF) | 0.147289 | ||
20-Day SMA (CHF) | 4.23875 | ||
12-1 Month Momentum % | 23.9 | ||
52-Week Range (CHF) | 3.04 - 9.39 | ||
Shares Outstanding (Mil) | 33.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Molecular Partners AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Molecular Partners AG Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Molecular Partners AG Frequently Asked Questions
What is Molecular Partners AG(LTS:0QXX)'s stock price today?
When is next earnings date of Molecular Partners AG(LTS:0QXX)?
Does Molecular Partners AG(LTS:0QXX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |